1. Exploring the Feasibility of Comprehensive Uncertainty Assessment in Health Economic Modeling: A Case Study
- Author
-
Arina J. ten Cate-Hoek, Bram Ramaekers, Svenja Petersohn, Sabine Grimm, Manuela A. Joore, Health Services Research, RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: Carim - B04 Clinical thrombosis and Haemostasis, MUMC+: KIO Kemta (9), and Biochemie
- Subjects
Technology Assessment, Biomedical ,SAMPLE ,INFORMATION ,Computer science ,Cost effectiveness ,Cost-Benefit Analysis ,GUIDELINES ,COST-EFFECTIVENESS ,EVENTS ,03 medical and health sciences ,0302 clinical medicine ,Multidisciplinary approach ,DECISION-ANALYTIC MODELS ,STRUCTURAL UNCERTAINTY ,030212 general & internal medicine ,uncertainty analysis ,Risk management ,Uncertainty analysis ,PERFECT ,business.industry ,030503 health policy & services ,Health Policy ,Uncertainty ,Public Health, Environmental and Occupational Health ,Probabilistic logic ,Health technology ,Expert elicitation ,Economics, Medical ,ASPIRIN ,Risk analysis (engineering) ,EXPECTED VALUE ,Organizational Case Studies ,Feasibility Studies ,Economic model ,0305 other medical science ,business - Abstract
Objectives: Decision makers adopt health technologies based on health economic models that are subject to uncertainty. In an ideal world, these models parameterize all uncertainties and reflect them in the cost-effectiveness probability and risk associated with the adoption. In practice, uncertainty assessment is often incomplete, potentially leading to suboptimal reimbursement recommendations and risk management. This study examines the feasibility of comprehensive uncertainty assessment in health economic models.Methods: A state transition model on peripheral arterial disease treatment was used as a case study. Uncertainties were identified and added to the probabilistic sensitivity analysis if possible. Parameter distributions were obtained by expert elicitation, and structural uncertainties were either parameterized or explored in scenario analyses, which were model averaged.Results: A truly comprehensive uncertainty assessment, parameterizing all uncertainty, could not be achieved. Expert elicitation informed 8 effectiveness, utility, and cost parameters. Uncertainties were parameterized or explored in scenario analyses and with model averaging. Barriers included time and resource constraints, also of clinical experts, and lacking guidance regarding some aspects of expert elicitation, evidence aggregation, and handling of structural uncertainty. The team's multidisciplinary expertise and existing literature and tools were facilitators.Conclusions: While comprehensive uncertainty assessment may not be attainable, improvements in uncertainty assessment in general are no doubt desirable. This requires the development of detailed guidance and hands-on tutorials for methods of uncertainty assessment, in particular aspects of expert elicitation, evidence aggregation, and handling of structural uncertainty. The issue of benefits of uncertainty assessment versus time and resources needed remains unclear.
- Published
- 2021